ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Updates in the Management of Cervical Cancer

Abdulrahman Sinno

ESMO 2024 Summary: Advances in Cervical Cancer Management - Comprehe…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

ESMO 2024 Insights: OS Results for Pembro + CRT for High-Risk Locall…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

Cancer Screening Molecular Tools

Fengting Yan

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

UCLA Health

G. Konecny

Updates in the Management of Locally Advanced Cervical Cancer

Jill Remick

2024 Updates in Cervical Cancer

Total Health

T. Tillmanns

ESMO 2024 Summary: Antibody Drug Conjugates (ADCs) - Identifying New…

2024 ESMO Annual Meeting Insights Hub

S. Banerjee

Updates on Cervical Cancer Screening: Where We Are, and Where We're …

Yale Cancer Center

H. Walden

ASCO® 2024 Insights: "BrUOG 354 Trial Final Results - Nivo vs. Nivo/…

2024 ASCO® Annual Meeting Insights Hub

D. Dizon

Overview of Cervical Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

Top Risk Factors for Cancer by Sex and What to Do About It

MedCram

R. Seheult

SGO 2024 Insights: "Impact of Maintenance Bevacizumab Following Chem…

Insights from 2024 SGO Annual Meeting

M. Kuznicki

ESMO 2024 Insights: Induction Chemo Followed by CRT in Advanced Cerv…

2024 ESMO Annual Meeting Insights Hub

G. Eminowicz